filings.toolsCover and table of contents
19K characters. Original on sec.gov · Markdown
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
| ☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended January 3, 2025
or
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 001-33072
| Leidos Holdings, Inc. | ||||||||
| (Exact name of registrant as specified in its charter) |
| Delaware | 20-3562868 | ||||||||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||||||||||||||
| 1750 Presidents Street, | Reston, | Virginia | 20190 | ||||||||||||||
| (Address of principal executive offices) | (Zip Code) |
(571) 526-6000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||||||||
| Common stock, par value $.0001 per share | LDOS | New York Stock Exchange |
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | x | Accelerated filer | ☐ | ||||||||||||||||||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||||||||||||||||||||||
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. x
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. o
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No x
As of June 28, 2024, which was the last business day of the registrant’s most recently completed second fiscal quarter, the aggregate market value of Leidos Holdings, Inc. common stock (based upon the closing price of the stock on the New York Stock Exchange) held by non-affiliates of the registrant was $19,549,744,128.
The number of shares issued and outstanding of the registrant’s class of common stock as of February 4, 2025, was 131,167,372 shares ($.0001 par value per share).
DOCUMENTS INCORPORATED BY REFERENCE
Portions of Leidos Holdings, Inc.’s definitive Proxy Statement for the 2024 Annual Meeting of Stockholders (”2025 Proxy Statement”) are incorporated by reference in Part III of this Annual Report on Form 10-K.
LEIDOS HOLDINGS, INC. FORM 10-K
Table of Contents
LEIDOS HOLDINGS, INC. FORM 10-K
Forward-Looking Statements
This Annual Report on Form 10-K contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that are based on our management’s belief and assumptions about the future in light of information currently available to our management. In some cases, you can identify forward-looking statements by words such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” and similar words or phrases or the negative of these words or phrases. These statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable when made, we cannot guarantee future results, levels of activity, performance or achievements. There are a number of important factors that could cause our actual results to differ materially from those results anticipated by our forward-looking statements, which include, but are not limited to:
udevelopments in the U.S. government defense and non-defense budgets, including budget reductions, sequestration, implementation of spending limits or changes in budgetary priorities, delays in the U.S. government budget process or a government shutdown, or the U.S. government’s failure to raise the debt ceiling, which increases the possibility of a default by the U.S. government on its debt obligations, related credit-rating downgrades, or an economic recession;
uuncertainties in tax due to new tax legislation or other regulatory developments;
udeterioration of economic conditions or weakening in credit or capital markets;
uuncertainty in the consequences of current and future geopolitical events;
uinflationary pressures and fluctuations in interest rates;
udelays in the U.S. government contract procurement process or the award of contracts and delays or loss of contracts as a result of competitor protests;
uchanges in U.S. government procurement rules, regulations and practices, including its organizational conflict of interest rules;
uchanges in global trade policies, tariffs and other measures that could restrict international trade;
uincreased preference by the U.S. government for minority-owned, small and small disadvantaged businesses;
ufluctuations in foreign currency exchange rates;
uour compliance with various U.S. government and other government procurement rules and regulations;
ugovernmental reviews, audits and investigations of our company;
uour ability to effectively compete and win contracts with the U.S. government and other customers;
uour ability to respond rapidly to emerging technology trends, including the use of artificial intelligence;
uour reliance on information technology spending by hospitals/healthcare organizations;
uour reliance on infrastructure investments by industrial and natural resources organizations;
uenergy efficiency and alternative energy sourcing investments;
uinvestments by U.S. government and commercial organizations in environmental impact and remediation projects;
uthe effects of an epidemic, pandemic or similar outbreak may have on our business, financial position, results of operations and/or cash flows;
uour ability to attract, train and retain skilled employees, including our management team, and to obtain security clearances for our employees;
uour ability to accurately estimate costs, including cost increases due to inflation, associated with our firm-fixed-price (“FFP”) contracts and other contracts;
uresolution of legal and other disputes with our customers and others or legal or regulatory compliance issues;
ucybersecurity, data security or other security threats, system failures or other disruptions of our business;
| Leidos Holdings, Inc. Annual Report | 1 |
LEIDOS HOLDINGS, INC. FORM 10-K
uour compliance with international, federal, state and local laws and regulations regarding privacy, data security, protection, storage, retention, transfer, disposal and other processing, technology protection and personal information;
uthe damage and disruption to our business resulting from natural disasters and the effects of climate change;
uour ability to effectively acquire businesses and make investments;
uour ability to maintain relationships with prime contractors, subcontractors and joint venture partners;
uour ability to manage performance and other risks related to customer contracts;
uthe failure of our inspection or detection systems to detect threats;
uthe adequacy of our insurance programs, customer indemnifications or other liability protections designed to protect us from significant product or other liability claims, including cybersecurity attacks;
uour ability to manage risks associated with our international business;
uour ability to comply with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act of 2010 and similar worldwide anti-corruption and anti-bribery laws and regulations;
uour ability to protect our intellectual property and other proprietary rights by third parties of infringement, misappropriation or other violations by us of their intellectual property rights;
uour ability to prevail in litigation brought by third parties of infringement, misappropriation or other violations by us of their intellectual property rights;
uour ability to declare or increase future dividends based on our earnings, financial condition, capital requirements and other factors, including compliance with applicable law and our agreements;
uour ability to grow our commercial health and infrastructure businesses, which could be negatively affected by budgetary constraints faced by hospitals and by developers of energy and infrastructure projects;
uour ability to successfully integrate acquired businesses; and
uour ability to execute our business plan and long-term management initiatives effectively and to overcome these and other known and unknown risks that we face.
We do not undertake any obligation to update or revise any of the forward-looking statements to reflect events, circumstances, changes in expectations, or the occurrence of unanticipated events after the date of those statements or to conform these statements to actual results.
| 2 | Leidos Holdings, Inc. Annual Report |
Part I